Brain Advance Access originally published online on February 2, 2005
Brain 2005 128(3):570-583; doi:10.1093/brain/awh397
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response
1 Movement Disorders and Neurophysiology Units, Centro Internacional de Restauracion Neurologica (CIREN), La Habana, Cuba, 2 Departments of Neurology and Neurosurgery, Neuroscience Center, Clinica Universitaria and Medical School, University of Navarra and FIMA, Pamplona, 3 Department of Neurology, University Hospital, Barcelona, Spain, 4 Department of Neurology, Emory University School of Medicine, Atlanta, GA, 5 Movement Disorders Program, Department of Neurology, University of Louisville School of Medicine, Louisville, KY and 6 Department of Neurology, Mount Sinai Medical School, New York, USA
Correspondence to: Jose A. Obeso, Neurologia-Neurociencias, Clinica Universitaria, Avenida Pio XII, 36, Pamplona 31008, Spain E-mail: jobeso{at}unav.es
We conducted an open label pilot study of the effect of bilateral subthalamotomy in 18 patients with advanced Parkinson's disease. In seven patients, the first subthalamotomy pre-dated the second by 12–24 months (‘staged surgery’). Subsequently, a second group of 11 patients received bilateral subthalamotomy on the same day (‘simultaneous surgery’). Patients were assessed according to the CAPIT (Core Assessment Program for Intracerebral Transplantation) protocol, a battery of timed motor tests and neuropsychological tests. Evaluations were performed in the ‘off’ and ‘on’ drug states before surgery and at 1 and 6 months and every year thereafter for a minimum of 3 years after bilateral subthalamotomy. Compared with baseline, bilateral subthalamotomy induced a significant (P < 0.001) reduction in the ‘off’ (49.5%) and ‘on’ (35.5%) Unified Parkinson's Disease Rating Scale (UPDRS) motor scores at the last assessment. A blind rating of videotape motor exams in the ‘off’ and ‘on’ medication states preoperatively and at 2 years postoperatively also revealed a significant improvement. All of the cardinal features of Parkinson's disease as well as activities of daily living (ADL) scores significantly improved (P < 0.01). Levodopa-induced dyskinesias were reduced by 50% (P < 0.01), and the mean daily levodopa dose was reduced by 47% at the time of the last evaluation compared with baseline (P < 0.0001). Dyskinesias occurred intraoperatively or in the immediate postoperative hours in 13 patients, but were generally mild and short lasting. Three patients developed severe generalized chorea that gradually resolved within the next 3–6 months. Three patients experienced severe and persistent postoperative dysarthria. In two, this coincided with the patients exhibiting large bilateral lesions also suffering from severe dyskinesias. No patient exhibited permanent cognitive impairment. The motor benefit has persisted for a follow-up of 3–6 years. This study indicates that bilateral subthalamotomy may induce a significant and long-lasting improvement of advanced Parkinson's disease, but the clinical outcome was variable. This variability may depend in large part on the precise location and volume of the lesions. Further refinement of the surgical procedure is mandatory.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Deligny, S. Drapier, M. Verin, Y. Lajat, S. Raoul, and P. Damier BILATERAL SUBTHALAMOTOMY THROUGH DBS ELECTRODES: A RESCUE OPTION FOR DEVICE-RELATED INFECTION Neurology, October 13, 2009; 73(15): 1243 - 1244. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tarsy Does subthalamotomy have a place in the treatment of Parkinson's disease? J. Neurol. Neurosurg. Psychiatry, September 1, 2009; 80(9): 939 - 940. [Full Text] [PDF]
|
|
|
|
|
|
L Alvarez, R Macias, N Pavon, G Lopez, M C Rodriguez-Oroz, R Rodriguez, M Alvarez, I Pedroso, J Teijeiro, R Fernandez, et al. Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months J. Neurol. Neurosurg. Psychiatry, September 1, 2009; 80(9): 979 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Olanow, M. B. Stern, and K. Sethi The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology, May 26, 2009; 72(21_Supplement_4): S1 - S136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Atherton, D. L. Wokosin, S. Ramanathan, and M. D. Bevan Autonomous initiation and propagation of action potentials in neurons of the subthalamic nucleus J. Physiol., December 1, 2008; 586(23): 5679 - 5700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mukhida, M. Hong, G.B. Miles, T. Phillips, B.A. Baghbaderani, M. McLeod, N. Kobayashi, A. Sen, L.A. Behie, R.M. Brownstone, et al. A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats Brain, August 1, 2008; 131(8): 2106 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Baufreton and M. D. Bevan D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus J. Physiol., April 15, 2008; 586(8): 2121 - 2142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Papapetropoulos, J. R. Jagid, C. Sengun, C. Singer, and B. V. Gallo Objective monitoring of tremor and bradykinesia during DBS surgery for Parkinson disease Neurology, April 8, 2008; 70(15): 1244 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ramanathan, T. Tkatch, J. F. Atherton, C. J. Wilson, and M. D. Bevan D2-Like Dopamine Receptors Modulate SKCa Channel Function in Subthalamic Nucleus Neurons Through Inhibition of Cav2.2 Channels J Neurophysiol, February 1, 2008; 99(2): 442 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Temel, L. J. Boothman, A. Blokland, P. J. Magill, H. W. M. Steinbusch, V. Visser-Vandewalle, and T. Sharp Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus PNAS, October 23, 2007; 104(43): 17087 - 17092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Boulet, E. Lacombe, C. Carcenac, C. Feuerstein, V. Sgambato-Faure, A. Poupard, and M. Savasta Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata. J. Neurosci., October 18, 2006; 26(42): 10768 - 10776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Merello, S Perez-Lloret, J Antico, and J A Obeso Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine J. Neurol. Neurosurg. Psychiatry, February 1, 2006; 77(2): 172 - 174. [Abstract] [Full Text] [PDF]
|
|